These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29138008)
1. G-quadruplex structure at intron 2 of TFE3 and its role in Xp11.2 translocation and splicing. Verma SP; Das P Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):630-636. PubMed ID: 29138008 [TBL] [Abstract][Full Text] [Related]
2. Novel splicing in IGFN1 intron 15 and role of stable G-quadruplex in the regulation of splicing in renal cell carcinoma. Verma SP; Das P PLoS One; 2018; 13(10):e0205660. PubMed ID: 30335789 [TBL] [Abstract][Full Text] [Related]
3. Exploring G-quadruplex structure in PRCC-TFE3 fusion oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC). Neha N; Das P J Biotechnol; 2024 Jul; 390():39-49. PubMed ID: 38740306 [TBL] [Abstract][Full Text] [Related]
4. Dual role of G-quadruplex in translocation renal cell carcinoma: Exploring plausible Cancer therapeutic innovation. Neha ; Das P; Verma SP Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129719. PubMed ID: 32882363 [TBL] [Abstract][Full Text] [Related]
5. TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas. Yin X; Wang B; Gan W; Zhuang W; Xiang Z; Han X; Li D J Exp Clin Cancer Res; 2019 Mar; 38(1):119. PubMed ID: 30849994 [TBL] [Abstract][Full Text] [Related]
6. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503 [TBL] [Abstract][Full Text] [Related]
7. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965 [TBL] [Abstract][Full Text] [Related]
8. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma. Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774 [TBL] [Abstract][Full Text] [Related]
9. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels. Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413 [TBL] [Abstract][Full Text] [Related]
10. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027 [TBL] [Abstract][Full Text] [Related]
11. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern. Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913 [TBL] [Abstract][Full Text] [Related]
12. G-quadruplex formation enhances splicing efficiency of PAX9 intron 1. Ribeiro MM; Teixeira GS; Martins L; Marques MR; de Souza AP; Line SR Hum Genet; 2015 Jan; 134(1):37-44. PubMed ID: 25204874 [TBL] [Abstract][Full Text] [Related]
13. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182 [TBL] [Abstract][Full Text] [Related]
14. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma. Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891 [TBL] [Abstract][Full Text] [Related]
15. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Chang IW; Huang HY; Sung MT Am J Surg Pathol; 2009 Dec; 33(12):1894-901. PubMed ID: 19809274 [TBL] [Abstract][Full Text] [Related]
16. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422 [TBL] [Abstract][Full Text] [Related]
17. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Clark J; Lu YJ; Sidhar SK; Parker C; Gill S; Smedley D; Hamoudi R; Linehan WM; Shipley J; Cooper CS Oncogene; 1997 Oct; 15(18):2233-9. PubMed ID: 9393982 [TBL] [Abstract][Full Text] [Related]
18. Optimal antisense target reducing INS intron 1 retention is adjacent to a parallel G quadruplex. Kralovicova J; Lages A; Patel A; Dhir A; Buratti E; Searle M; Vorechovsky I Nucleic Acids Res; 2014 Jul; 42(12):8161-73. PubMed ID: 24944197 [TBL] [Abstract][Full Text] [Related]
19. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements. Lee SJ; Yang WI; Chung WS; Kim SK Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265 [TBL] [Abstract][Full Text] [Related]
20. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]